The word “cancer” alone is enough to make anyone uneasy. When a doctor follows it with a recommendation for a biopsy, that anxiety can quickly grow. For decades, a lingering fear has circulated among patients: that inserting a needle into a tumor or cutting into it could disturb cancer cells and cause them to spread to other parts of the body.
Many people have long worried that the very test meant to detect and treat the disease could somehow put them at greater risk. In recent years, however, the medical community has begun addressing these concerns more openly. So the question remains — can biopsies spread cancer?
The answer isn’t as simple as a straightforward “yes” or “no.” Doctors acknowledge that a phenomenon known as Tumor Seeding can occur in rare cases. Still, the broader scientific consensus is clear: the benefits of performing a biopsy far outweigh the potential risks. To understand why, it’s important to look beyond alarming headlines and examine how biopsies actually work and what the research shows.
What exactly is a biopsy?
Before addressing concerns about cancer spreading, it’s important to understand what a biopsy is and why doctors perform it. A biopsy is a medical procedure in which a small sample of tissue, cells, or fluid is taken from a suspicious area of the body. The sample is then sent to a pathologist — a specialist who studies cells — and examined under a powerful microscope.
There are several types of biopsies. These can range from a fine-needle aspiration to a core needle biopsy, which uses a slightly larger needle, as well as surgical biopsies where part of a lump is removed.
So why is this necessary? Despite major advances in modern medicine, imaging tests such as CT scan, MRI, and X-ray have their limits. They can reveal that a spot or shadow exists, but they cannot determine with complete certainty what it actually is.
It might be a benign cyst, an infection, or a malignant tumor. A biopsy remains the “gold standard” for diagnosis, helping doctors identify the exact type of cancer, determine how aggressive it is, and decide which treatments — such as targeted therapy or immunotherapy — are most likely to work.
“Biopsies often provide essential information to help diagnose and stage cancer. They can also help inform decision-making for individuals who receive a cancer diagnosis,” said Jeffrey E. Gershenwald, an expert with the American Society of Clinical Oncology and a professor in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center.
Understanding the concept of “tumor seeding”
The technical term behind this concern is Tumor Seeding, sometimes referred to as needle tract seeding. It describes the rare situation in which a biopsy needle, when withdrawn from a tumor, might carry a few cancer cells along the path it traveled and deposit them into nearby healthy tissue.
It’s important to be clear: doctors are not “admitting” this as some hidden secret. The possibility has been studied, documented, and carefully monitored for decades. Medical researchers have tracked the occurrence of seeding across millions of procedures. What the evidence consistently shows is that while the process is biologically possible, it happens extremely rarely.
Table of Contents
Examining the numbers: is the risk real?
When the data is examined, the alarming claims sometimes seen in sensational headlines begin to lose their weight. According to the American Cancer Society and multiple clinical studies, the rate of needle tract seeding is so low that for many cancers it is considered statistically negligible. For example:
Liver cancer: A major review reported that needle tract seeding occurred in about 2.7% of cases.
Breast cancer: Large studies involving thousands of patients show the risk of seeding is extremely low. More importantly, undergoing a needle biopsy does not reduce a patient’s survival chances or increase the likelihood of the cancer returning.
Prostate and lung cancers: Similar patterns appear here as well. The diagnostic benefit of a biopsy is substantial, while documented cases of spread caused by the needle remain rare exceptions rather than a common complication.
In a 2015 study, researchers reviewing years of medical data found that the overall rate of seeding across different cancers was below 1%. In comparison, the risk of cancer going undiagnosed or being treated incorrectly because a biopsy was avoided is significantly higher and far more dangerous.
“This study shows that physicians and patients should feel reassured that a biopsy is very safe,” said Michael Wallace. “We perform millions of cancer biopsies every year in the U.S., but one or two isolated case studies have helped fuel the myth that biopsies spread cancer.”
Why doesn’t a “seed” always grow?
Even if a few cells were displaced during a biopsy, that does not mean a new tumor will form.
The human body is not a passive environment. It is often hostile to stray cells. Cancer cells are adapted to survive within their own tumor microenvironment, and once displaced, they face several major challenges.
The immune system: The body’s immune defenses constantly search for abnormal or misplaced cells. In many cases, stray cancer cells are destroyed before they can establish themselves.
Lack of blood supply: For cancer to grow, cells need access to a blood supply through a process called angiogenesis. Cells left along a needle track rarely have the conditions needed to build that support system.
Immediate treatment: Most biopsies are quickly followed by treatments such as surgery, chemotherapy, or radiation. These therapies target cancer cells throughout the area, including any that might have been displaced during the diagnostic procedure.
How doctors reduce the risk
How doctors reduce the risk
Medical professionals do not ignore the possibility of Tumor Seeding. Instead, they use specific techniques designed to minimize the risk. If you undergo a biopsy, your medical team will likely rely on one or more of the following precautions:
Coaxial needles: Many physicians use a sleeve or sheath method. A larger hollow needle is first placed near the edge of the tumor, and a smaller biopsy needle is then passed through that sleeve to collect the tissue sample. When the biopsy needle is withdrawn, it remains inside the sleeve, preventing the sample from touching healthy tissue along the needle’s path.
Surgical planning: When surgeons perform a biopsy on a tumor they expect to remove later, they carefully plan the needle’s path. In many cases, the biopsy track is placed in an area that will be completely removed during surgery. This means that even if seeding occurred, the affected tissue would be removed during the operation.
Fine-needle precision: Using smaller needles helps reduce tissue disruption, further lowering the already small chance of cancer cells being displaced.
The greater danger: the “wait and see” approach
Fear that a biopsy might spread cancer can sometimes lead people to avoid the procedure altogether, which carries a far greater risk. Cancer is usually most treatable — and often curable — when detected early. Delaying diagnosis allows a tumor to continue growing. Unlike the very small theoretical risk linked to a biopsy needle, an untreated tumor can eventually spread through the lymphatic system or bloodstream if left unchecked.
Without a biopsy, doctors are essentially working without critical information. They cannot determine whether a tumor requires aggressive chemotherapy or a more localized surgical treatment. Choosing the wrong treatment due to an incomplete diagnosis can have serious consequences. In oncology, accurate information is one of the most important tools available, and a biopsy provides that clarity.
Addressing the “admissions”
Some headlines suggest that doctors are “finally admitting” this risk, implying that the medical community once hid the information. In reality, physicians have long discussed the potential risks of procedures — whether it involves a biopsy, routine surgery, or a new medication — as part of the informed consent process.
Doctors talk openly about these possibilities because they want patients to be active participants in their care. Organizations such as the American Society of Clinical Oncology provide detailed information not to alarm patients but to clear up misconceptions that often spread when reliable information is lacking. By acknowledging that even a very small risk exists, doctors can explain the precautions they take to keep patients safe.
Important questions to ask your doctor
If you’re scheduled for a biopsy and feeling anxious, open communication can help ease those worries. Patients have the right to ask their medical team about how the procedure will be carried out. Some useful questions include:
- What type of biopsy will you perform, and why is it the best option for me?
- What measures are taken to keep the procedure safe?
- How will the biopsy results affect my treatment plan?
- What are the risks if I decide not to have the biopsy?
A good doctor will welcome these questions. They know that the possibility of cancer is one of the most stressful situations a person can face, and they want patients to feel assured about their care plan.
Keeping fear in perspective
It’s natural for people to dwell on “what if” scenarios. The thought that a needle could spread cancer is one of those frightening possibilities.
But scientific research and decades of clinical evidence offer an important reality check. Although Tumor Seeding is a documented phenomenon, it occurs so rarely that it does not change the central fact: biopsies save lives.
In most cases, the spread of cancer happens because of the disease’s natural progression, not because of the tools used to detect it.
Choosing to undergo a biopsy gives patients the best chance for an effective outcome. It moves them from uncertainty and fear toward clarity and action.
Headlines may sometimes frame this risk as a dramatic “admission,” but in reality, doctors are simply being transparent about a risk they already understand and know how to manage.
The real story is not that biopsies are dangerous, but that they are a refined and essential part of modern medicine, helping thousands of people fight cancer every day. A small theoretical risk should not stand in the way of the certainty needed to pursue proper treatment.